Purchase Order 75N91018P00404

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on March 15, 2018, with ultimate completion on April 13, 2018. The order covers laboratory supplies under firm fixed price terms. Place of performance is Pleasanton, California.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $5,600 on November 16, 2017, for laboratory supplies. Performance location is Pleasanton, California. The order carries a firm fixed price and ultimate completion date of December 31, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for lab supplies valued at $5,847.00 on January 4, 2018, with completion targeted for February 2, 2018. Performance occurs in Pleasanton, California. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,660.00 on June 27, 2017, for laboratory supplies. Performance occurs in Pleasanton, California, with an ultimate completion date of July 21, 2017. The order covers 10X Genomics single-cell and spatial transcriptomics reagents and consumables supplied under firm fixed price, with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,554.00 on August 22, 2017, with a completion date of September 21, 2017. The order covers laboratory supplies, with place of performance in Pleasanton, California. Pricing is firm fixed price under a no-set-aside simplified acquisition.</p>

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc. valued at $5,850.00 on February 22, 2018, for laboratory supplies. Performance takes place in Pleasanton, California, with an ultimate completion date of March 23, 2018. This is a firm fixed-price purchase order with no set-aside applied.</p>

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc., for $5,850 on April 26, 2018, to supply laboratory reagents and genomic analysis consumables. Performance occurs at 10X Genomics' facility in Pleasanton, California, with ultimate completion by May 25, 2018. The order is priced on a firm fixed price basis with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on March 6, 2018, for a maintenance agreement, with completion by April 4, 2018. Performance occurs in Pleasanton, California. The order is a firm fixed price acquisition with no set-aside applied.</p>

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc. for $22,366.00 in lab supplies, awarded August 15, 2017, with completion by September 13, 2017. Performance occurs at 10X Genomics' facility in Pleasanton, California. The order is firm fixed price with no set-aside category.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on July 11, 2018. Work is performed in Pleasanton, California. The order carries no set-aside designation and is priced on a firm fixed price basis. Ultimate completion is scheduled for July 10, 2019.</p>